Inflammatory Resolution: new opportunities for drug discovery
Authors:
- Derek W. GilroyDerek W. Gilroy
- Toby LawrenceTLToby Lawrence
- Mauro PerrettiMPMauro Perretti
- Adriano G. RossiARAdriano G. Rossi
- 1 May 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (5) , 401-416
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen‐induced arthritisArthritis & Rheumatism, 2004
- A decade of caspasesOncogene, 2003
- Potentiation of Protein Kinase C ζ Activity by 15-Deoxy-Δ12,14-Prostaglandin J2 Induces an Imbalance between Mitogen-Activated Protein Kinases and NF-κB That Promotes Apoptosis in MacrophagesMolecular and Cellular Biology, 2003
- Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX‐68Arthritis & Rheumatism, 2003
- Aberrant inflammation and resistance to glucocorticoids in Annexin 1 −/− MouseThe FASEB Journal, 2002
- Adhesion Molecule–dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal InflammationJournal of Experimental Medicine, 2002
- Natural ligands of PPARγ:Cellular Signalling, 2002
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.Journal of Experimental Medicine, 1996
- Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensionsBiochemical and Biophysical Research Communications, 1988